Top Markets
#1 DogBull DogBull +54.73%
#2 Siren Siren +31.33%
#3 OriginTrail OriginTrail +17.13%
#4 龙虾 (Lobster) 龙虾 (Lobster) +9.48%
#5 Yield Basis Yield Basis +9.42%
#6 Verus Coin Verus Coin +7.40%
#7 Stargate Finance Stargate Finance +7.16%
#8 Collect on Fanable Collect on Fanable +6.91%
#9 LayerZero LayerZero +6.90%
#10 COTI COTI +6.55%
Coin of the day
DogBull DogBull
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rang in aandelen #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Aandeelprijs
$0.3479
Laatst gesynchroniseerd: 2024-08-21
Marktkapitalisatie
$94.92M
Verandering (1 dag)
0.64%
Verandering (1 jaar)
0.00%
Land
US
Handel Asensus Surgical, Inc. (ASXC)

Categorie

Healthcare
Operationele marge voor Asensus Surgical, Inc. (ASXC)
Operationele marge op August 2026 TTM: -926.52%
Volgens de meest recente financiële rapporten en aandelenkoers van Asensus Surgical, Inc. is de huidige operationele marge (TTM) -926.52%. Eind 2022 had het bedrijf een operationele marge van -1,067.86%.
Geschiedenis van de operationele marge van Asensus Surgical, Inc. van 2000 tot 2026
Operationele marge aan het einde van elk jaar
Jaar Operationele Marge Wijzigen
2026 (TTM) -926.52% 0.00%
2023 -926.52% -13.24%
2022 -1,067.86% 36.04%
2021 -784.97% -58.73%
2020 -1,902.02% 4.97%
2019 -1,811.92% 788.50%
2018 -203.93% -76.58%
2017 -870.86% -89.30%
2016 -8,140.16% 0.00%
2015 0.00% -100.00%
2014 -9,129.43% 410.24%
2013 -1,789.24% 468.63%
2012 -314.66% 0.00%
2011 0.00% -100.00%
2010 18,431.03% 0.00%
2009 0.00% 0.00%
2008 0.00% -100.00%
2007 2,052.59% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% -100.00%
2003 -462.77% 1,370.04%
2002 -31.48% 842.51%
2001 -3.34% -265.35%
2000 2.02% 0.00%
Operationele marge van vergelijkbare bedrijven of concurrenten
Bedrijf Operationele Marge Verschil in operationele marge Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.02%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.02%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.02%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.02%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.